Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Prevalence and Treatment of Hypertension Complicated by Comorbid Conditions.

Meier JL, Lopez J, Siegel D. Prevalence and Treatment of Hypertension Complicated by Comorbid Conditions. Journal of clinical hypertension (Greenwich, Conn.). 1999 Nov 1; 1(3):209-211.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

Although the presence of a comorbid condition should be an important factor in etermining the choice of an antihypertensive agent, the prevalence of conditions complicating hypertension is unknown in most patient populations. It is also unknown whether the presence of comorbid conditions influences antihypertensive therapy. To address these questions, we determined the prevalence of comorbid conditions and antihypertensive prescribing patterns for 7526 patients receiving antihypertensive medication at four Department of Veterans Affairs clinics. Of these patients, 97% were male and 86% were over 50 years of age. In these hypertensives, 2507 had coronary artery disease (CAD), 2426 had diabetes mellitus (DM), 1553 had chronic obstructive pulmonary disease (COPD) or asthma, and 970 had congestive heart failure (CHF). The presence of comorbid conditions did not have a major impact on the choice of antihypertensive agents, with most hypertensives receiving calcium antagonists or ACE inhibitors. The use of à -blockers, for example, was not greatly influenced by the presence of CAD. (c)1999 by Le JacqCommunications, Inc.





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.